Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 11;8(1):10.
doi: 10.1186/1750-9378-8-10.

Histone de-acetylase inhibitors: a promising future for cancer treatment?

Affiliations

Histone de-acetylase inhibitors: a promising future for cancer treatment?

Raja Samir Khan et al. Infect Agent Cancer. .
No abstract available

PubMed Disclaimer

References

    1. Bottomley MJ, Lo Surdo P, Di Giovine P, Cirillo A, Scarpelli R, Ferrigno F, Jones P, Neddermann P. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain. J Biol Chem. 2008;283(39):26694–26704. doi: 10.1074/jbc.M803514200. - DOI - PMC - PubMed
    1. Choudhary C. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325(5942):834–840. doi: 10.1126/science.1175371. - DOI - PubMed
    1. Bertos NR, Wang AH, Yang XJ. Class II histone deacetylases: structure, function, and regulation. Biochem Cell Biol. 2001;79(3):243–252. doi: 10.1139/o01-032. - DOI - PubMed
    1. Glozak MA, Seto E. Histone deacetylases and cancer. Oncogene. 2007;26:5420–5432. doi: 10.1038/sj.onc.1210610. - DOI - PubMed
    1. Jacobson S, Pillus L. Modifying chromatin and concepts of cancer. Curr Opin Genet Dev. 1999;9(2):175–184. doi: 10.1016/S0959-437X(99)80027-6. - DOI - PubMed

LinkOut - more resources